We believe in the potentials of microRNAs

We are going to contribute to regenerative medicine and drug discovery through exploration of active microRNAs.



01 April 2021

Executed a research collaboration agreement with JCR Pharmaceuticals.

Press release

15 Sept. 2020

Introduced in Startup Guide Japan.

12 Sept. 2020

Expanded our drug-resistant mRNA series: now puromycinR, blastcidinR, hygromycinR mRNA are available.

08 Sept. 2020

Selected for the Strategic Core Technology Advancement Program (Supporting Industry Program)

05 Nov. 2019

Successfully obtained Series A Funding.

30 Jul. 2019

Received the hosei-monodukuri' grant-in aid.

28 Jun. 2019

Commenced sales of RNA Switch reagents for cell purification.

19 Dec. 2018

Received the 'Kigyounomori/Sangakunomori' promotion for business grant from Kyotosaangyo 21.

09 Nov. 2018

Successfully obtained seed round funding.

27 Sep. 2018

Received the research & development grant from Mitsubishi UFJ Technology Development Foundation.



Our Philosophy: 

We commit ourselves to contribute to the fields of regerative medicine and drug discovery through exloration of novel funtions of microRNAs.



img20200708171927182994.png What is RNA Switch technology? img20200616113126068449.png RNA Switch for cardiomyocyte purification: CM purifier new_pitch_presentation_kh20200204.png Custom synthesis of RNA Switch screening.png RNA Switch Library and HTP Screening platform for disease-related microRNAs




We are a bio-venture originating from Kyoto University.

aceRNA Technology, co., ltd. was established in April 2018 in order to apply the RNA Switch technology, which was developed by Prof. Hirohide Saito (Center for iPS Cells Research and Application, Kyoto Uni.), to the fields of regenerative medicine and drug discovery. To set up the business, Prof. Saito teamed up with Dr. Teruo Susumu (our CEO) and Nobuhiro Yagi (KYOTO-iCAP), both of whom have extensive experiences in big pharma and venture capitals. Our office is located in Innovation Hub Kyoto on the campus of Kyoto University. Apart from Dr. Susumu, our team currently consists of four research scientists and an office clerk.